Boosting with an aerosolized Ad5-nCoV elicited robust immune responses in inactivated COVID-19 vaccines recipients

INTRODUCTION: The SARS-CoV-2 Omicron variant has become the dominant SARS-CoV-2 variant and exhibits immune escape to current COVID-19 vaccines, the further boosting strategies are required. METHODS: We have conducted a non-randomized, open-label and parallel-controlled phase 4 trial to evaluate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zhe, Wu, Shipo, Liu, Yawei, Li, Kailiang, Fan, Pengfei, Song, Xiaohong, Wang, Yudong, Zhao, Zhenghao, Zhang, Xianwei, Shang, Jin, Zhang, Jinlong, Xu, Jinghan, Li, Yao, Li, Yaohui, Zhang, Jipeng, Fu, Kefan, Wang, Busen, Hao, Meng, Zhang, Guanying, Long, Pengwei, Qiu, Ziyu, Zhu, Tao, Liu, Shuling, Zhang, Yue, Shao, Fangze, Lv, Peng, Yang, Yilong, Zhao, Xiaofan, Sun, Yufa, Hou, Lihua, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585368/
https://www.ncbi.nlm.nih.gov/pubmed/37868993
http://dx.doi.org/10.3389/fimmu.2023.1239179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10585368/
https://www.ncbi.nlm.nih.gov/pubmed/37868993
http://dx.doi.org/10.3389/fimmu.2023.1239179

Ejemplares similares